Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofrat Beyar-Katz

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 11, 2015
Host effects contributing to cancer therapy resistanceOfrat Beyar Katz, Yuval Shaked
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Novel Approaches to Acute Myeloid Leukemia ImmunotherapyOfrat Beyar-Katz, Saar Gill
Current Opinion in Hematology|September 14, 2020
Advances in chimeric antigen receptor T cellsOfrat Beyar-Katz, Saar Gill
Haematologica|August 21, 2025
After CAR-T therapy for myeloma: challenge of persistent cytopenias and infectionsOfrat Beyar-Katz, Anat Stern
Haematologica|March 5, 2026
Multiplex edited universal CAR T cells without the genomic costOfrat Beyar-Katz, Eric Shifrut
Haematologica|February 20, 2025
Immune effector cell-associated hematotoxicity: mechanisms, clinical manifestations, and management strategiesOfrat Beyar-Katz, Kai Rejeski, Roni Shouval
Current Protocols in Cell Biology|March 2, 2016
Analysis of the Stromal Cellular Components of the Solid Tumor Microenvironment Using Flow CytometryMichael Timaner, Ofrat Beyar-Katz, Yuval Shaked
Current Opinion in Hematology|January 31, 2016
Should autotransplantation in acute myeloid leukemia in first complete remission be revisited?Tsila Zuckerman, Ofrat Beyar-Katz, Jacob M Rowe
Acta Haematologica|October 9, 2023
Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?Ofrat Beyar Katz, Dana Yehudai-Ofir, Tsila Zuckerman
Thrombosis Research|July 30, 2015
Thrombosis in vasculitic disorders-clinical manifestations, pathogenesis and managementOfrat Beyar Katz, Benjamin Brenner, Netanel A Horowitz
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 11, 2015
Host effects contributing to cancer therapy resistanceOfrat Beyar Katz, Yuval Shaked
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Novel Approaches to Acute Myeloid Leukemia ImmunotherapyOfrat Beyar-Katz, Saar Gill
Current Opinion in Hematology|September 14, 2020
Advances in chimeric antigen receptor T cellsOfrat Beyar-Katz, Saar Gill
Haematologica|August 21, 2025
After CAR-T therapy for myeloma: challenge of persistent cytopenias and infectionsOfrat Beyar-Katz, Anat Stern
Haematologica|March 5, 2026
Multiplex edited universal CAR T cells without the genomic costOfrat Beyar-Katz, Eric Shifrut
Haematologica|February 20, 2025
Immune effector cell-associated hematotoxicity: mechanisms, clinical manifestations, and management strategiesOfrat Beyar-Katz, Kai Rejeski, Roni Shouval
Current Protocols in Cell Biology|March 2, 2016
Analysis of the Stromal Cellular Components of the Solid Tumor Microenvironment Using Flow CytometryMichael Timaner, Ofrat Beyar-Katz, Yuval Shaked
Current Opinion in Hematology|January 31, 2016
Should autotransplantation in acute myeloid leukemia in first complete remission be revisited?Tsila Zuckerman, Ofrat Beyar-Katz, Jacob M Rowe
Acta Haematologica|October 9, 2023
Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?Ofrat Beyar Katz, Dana Yehudai-Ofir, Tsila Zuckerman
Thrombosis Research|July 30, 2015
Thrombosis in vasculitic disorders-clinical manifestations, pathogenesis and managementOfrat Beyar Katz, Benjamin Brenner, Netanel A Horowitz
Pageof 5